Advertisement

Epstein-Barr Virus Gene Expression During Primary B-Lymphocyte Infection, in Transformed and Burkitt Lymphoma-Derived Cell Lines

  • I. Ernberg
  • B. Kallin
  • J. Dillner
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 132)

Abstract

Epstein-Barr virus (EBV) infection of resting human B-lymphocytes results in the establishment of transformed, continuously growing, virus genome carrying lymphoblastoid cell lines (LCL). This consequence of the virus infection is dependent on virus gene expression, as ultraviolet irradiation of EBV decreases the efficiency of transformation in a dose dependent manner. The early steps of the EBV infection shows many phenotypical parallels to B-lymphocyte activation obtained by mitogens and lymphokines in appropriate combinations. Thus EBV-induced B-lymphocyte activation defined as the first cell cycles after infection is one model from which conclusions can be made about signals involved in triggering of human B-lymphocytes. The expression and function of the virus coded proteins, which are present after EBV infection will be particularly usefool tools in providing knowledge about the significance of various steps in the B-lymphocyte activation. Some of these proteins may complement or replace cellular proteins that function in the physiologic, antigen induced lymphocyte activation. The cellular proteins cannot be identified so easily as those coded for by the virus, due to the availability of specific antibodies against the viral proteins.

Keywords

Lymphoblastoid Cell Line Virus Gene Expression Tumor Derive Cell Line Virus Nuclear Antigen Human Antiserum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adldinger HK, Delius H, Freese U, Clark J, Bornkamm GW (1985) A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141: 221–234PubMedCrossRefGoogle Scholar
  2. Bodescot M, Chambraud B, Farrell P, Perricaudet M (1984) Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polepeptide. The EMBO J 3: 1913–1917.Google Scholar
  3. Bodescot M, Brinson O, Perricaudet M (1986) An Epstein-Barr virus transcription unit is at least 84 kB long. Nucl. Acids Res 14: 2611–2620.Google Scholar
  4. Bornkamm GW, Delius H, Zimber U, Hudewentz J, Epstein MA (1980) Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J Virol 35: 603–618PubMedGoogle Scholar
  5. Dillner J, Kallin B, Ehiln-Henriksson B, Timar L, Klein G (1985) Characterization of a second Epstein-Barr virus determined nuclear antigen associated with the Bam H I WYH region of EBV DNA. Int J Cancer 35: 359–366.PubMedCrossRefGoogle Scholar
  6. Dillner J, Sternås L, Kallin B, Alexander H, Ehlin-Henriksson B, Jörnvall H, Klein G, Lerner R (1984) Antibodies against a synthetic peptide identify the Epstein_abrr virus determined nuclear antigen. Proc Natl Acad Sci, USA 81: 4652–4656.Google Scholar
  7. Dillner J, Kallin B, Alexander H, Ernberg I, Uno M, Ono Y, Klein G, Lerner R () A novel Epstein-Barr virus determined nuclear antigen (EBNA-5) partly encoded by the transformation-associated Bam WYH region of the EBV-DNA: differential expression in lymphoblastoid cell lines. Proc. Natl. Acad. Sci., in press.Google Scholar
  8. Einhorn L, Ernberg I (1978) Induction of EBNA precedes the first cellular S phase after EBV infection of human lymphocytes. Int J Cancer 21: 157–160.PubMedCrossRefGoogle Scholar
  9. Ernberg I (1979) Epstein-Barr virus productive and non productive host cell interaction. Academic thesis, Karolinska Institutet, Stockholm.Google Scholar
  10. Ernberg I, Kallin B, Dillner J, Falk K, Ehl in-Henr iksson B, Hammarskjöld ML, Klein G () Lymphoblastoid cell lines and Burkitt lymphoma derived cell lines differ in the expression of a second Epstein-Barr virus encodede nuclear antigen. Submiotted for publication.Google Scholar
  11. Hennessy K, Kieff E (1983) One of two Epstein_abrr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc Natl Acad Sci, USA 80: 5665–5669.Google Scholar
  12. Hennessy K, Kieff E (1985) A second nuclear protein is encoded by Epstein-Barr virus in latent infection. Science 227: 1238–1240.PubMedCrossRefGoogle Scholar
  13. Hennessy K, Fennewald S, Kieff E (1985) A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus. Proc Natl Acad Sci 82: 5944–5948.PubMedCrossRefGoogle Scholar
  14. Kallin B, Dillner J, Ernberg I, Ehlin-Henriksson B, Rosen A, Henle W, Henle G, Klein G (1986) Four virally determined antigens are expressed in Epstein-Barr virus transformed cells. Proc Natl Acad Sci 86: in press.Google Scholar
  15. Masucci M.G., Szigeti R., Ernberg,I., Hu C.-P., Torsteinsdottir S., Frade R., Klein E., Activation of B-lymphocytes by Epstein-Barr virus /CR 2 receptor interaction. Subm for publication.Google Scholar
  16. Ragona G, Ernberg I, Klein G (1980) Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma Virology 101, 553–557.Google Scholar
  17. Reedman B, Klein G (1973) Cellular localization of an Epstein-Barr virus ( EBV)-associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11, 499–520.Google Scholar
  18. Rowe D, Heston L, Hetlay J, Miller G (1985) Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonim- mortalizing deletion mutant, P3HR-I. Proc Natl Acad Sci 82: 7429–7433.Google Scholar
  19. Rymo L, Klein G, Ricksten A (1985) Expression of a second Epstein-Barr virus determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome. Proc Natl Acad Sci, USA 82: 3435–3439.Google Scholar
  20. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43: 831–840.PubMedCrossRefGoogle Scholar
  21. Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci, USA 81: 3806–3810.Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1986

Authors and Affiliations

  • I. Ernberg
    • 1
  • B. Kallin
    • 1
  • J. Dillner
    • 1
  1. 1.Department of Tumor BiologyKarolinska InstituteStockholmSweden

Personalised recommendations